MDDiabeticPro
Discover, Control & Prevent diabetic risk.
How does MDDiabeticPro differ from other diabetes tests?
PMLS offers a variety of biomarkers on our diabetes test panel. Besides running a normal A1C test, PMLS goes further and tests a patient’s Fasting Glucose, GlycoMark, Adiponectin, Leptin, HOMA-IR, Insulin, and C-peptide, but we don’t stop there. To give patient’s a look at the bigger picture, we also run a Comorbidity Assessment of Cardiovascular and Renal biomarkers, as well as a Genetic Predisposition test called DIABETESpredict™. With DIABETESpredict™, doctors can help their patients know their risk for type 2 diabetes earlier.
MdDiabeticPro is also specifically designed to help Type 1 diabetes patients with the management of the disease. This test can be used for monitoring individuals who are pre-disposed to insulin resistance. The results of the test equip physicians with the information needed to fine tune nutrition and exercise plans, helping a T1D patient to make the use of insulin most effective.
Know your risk with DIABETESPredict™
DIABETESpredict™ is a genotyping tool for type 2 diabetes risk assessment. It analyzes the main genetic variants associated with T2D, taking into account multi-ethnic associations. DIABETESpredict™ identifies high risk individuals and gives them additional information to implement lifestyle changes. Early identification of type 2 diabetes enables prevention and with DIABETESpredict™ doctors are empowered to help their patients further.
500 Million worldwide suffer
type-2 diabetes.
34.2 Million Americans, or 10.5% of the population, had diabetes.
Let’s Talk
We want to hear from you! Tell us more about your interest in MDChemistryPro today.
Read Our Blog
Premier Medical Laboratory Services Welcomes New Chief Commercial Officer, Jeff Schmalz
Premier Medical Laboratory Services (PMLS) is announcing today Jeff Schmalz as their new Chief Commercial Officer. At PMLS, Jeff will be focusing on the major disciplines impacting lab growth including partnerships, product development, clinical outreach, sales...
Scientific Panel Discussion Series: Dr. Brian Krueger and Dr. Stewart Holt
Premier Medical Laboratory Services addresses common COVID-19 questions As the first in a series of upcoming scientific panel discussions hosted at Premier Medical Laboratory Services (PMLS), Dr. Brian Krueger, Chief Scientific Officer of PMLS, and Dr. Stewart Holt,...
Reducing Antimicrobial Resistance (AMR) Through Precision Diagnostics
The growing global crisis of AMR poses a major threat to global health.1 As new resistance mechanisms emerge, it is becoming increasingly difficult to treat many common infectious diseases, none more so than Urinary Tract Infections (UTI). According to the CDC, there...
5 Things You Need to Know About Offering NIPT to Patients
As Non-Invasive Prenatal Testing (NIPT) is now offered at Premier Medical Laboratory Services, we want to offer resources for healthcare providers on the topic. In a recent GenomeWebinar sponsored by Illumina, Katie Ellis, Senior Genetic Counselor at Genea Fertility,...
Former Labcorp Technical Director of R&D, Brian Krueger Joins Premier Medical Laboratory Services as New Chief Scientific Officer
Brian Krueger, former Technical Director of R&D at Labcorp, joined the Premier Medical Laboratory Services (PMLS) team as the new Chief Scientific Officer. In this role, Krueger will be responsible for envisioning and overseeing the scientific functions of PMLS as...
Large Donation of COVID-19 Tests a Tremendous Help to Diabetes Summer Camps Across the Country
~ Premier Medical Laboratory Services donates rapid antigen tests to Diabetes Education and Camping Association Camps Like Camp Morris ~ Many children with diabetes look forward to summer camp each year to, not only spend time with friends, but with other children who...